Search Results

Effects of antipsychotic drugs on energy metabolism.

• Authors : Panizzutti, Bruna; Bortolasci, Chiara C.; Spolding, Briana

Subjects: DRUG metabolism; ENERGY metabolism; ANTIPSYCHOTIC agents

• Source: European Archives of Psychiatry & Clinical Neuroscience; Aug2024, Vol. 274 Issue 5, p1125-1135, 11p

Record details

How does a family history of psychosis influence the risk of methamphetamine‐related psychotic symptoms: Evidence from longitudinal panel data.

• Authors : McKetin, Rebecca; Clare, Philip J.; Castle, David

Subjects: HALLUCINATIONS; SUBSTANCE-induced psychoses; CONFIDENCE intervalsAUSTRALIA

• Source: Addiction; Oct2023, Vol. 118 Issue 10, p1975-1983, 9p, 2 Charts, 1 Graph

Record details

Impact of antipsychotic medication on IL‐6/STAT3 signaling axis in peripheral blood mononuclear cells of drug‐naive schizophrenia patients.

• Authors : Subbanna, Manjula (AUTHOR); Shivakumar, Venkataram (AUTHOR); Venugopal, Deepthi (AUTHOR)

Subjects: ANTIPSYCHOTIC agents; PEOPLE with schizophrenia; BLOOD cells

• Source: Psychiatry & Clinical Neurosciences. Jan2020, Vol. 74 Issue 1, p64-69. 6p. 4 Charts, 2 Graphs.

Record details

Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first‐episode psychosis (the STAGES study).

• Authors : O'Donoghue, Brian; Allott, Kelly; Harrigan, Susy

Subjects: ANTIPSYCHOTIC agents; RANDOMIZED controlled trials; YOUNG adults

• Source: Early Intervention in Psychiatry; Jun2023, Vol. 17 Issue 6, p597-607, 11p, 6 Charts, 1 Graph

Record details

Agricola

Record details

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.

• Authors : Neill, Erica; Rossell, Susan L; Yolland, Caitlin

Subjects: DRUG therapy for schizophrenia; MENTAL illness drug therapy; ACETYLCYSTEINEAUSTRALIA

• Source: Schizophrenia Bulletin; Nov2022, Vol. 48 Issue 6, p1263-1272, 10p

Record details

Gender‐specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.

• Authors : Jhon, Min; Yoo, Taeyoung; Lee, Ju‐Yeon

Subjects: BONE density; PSYCHOSES; PSYCHIATRIC treatment

• Source: Human Psychopharmacology: Clinical & Experimental. Jan2018, Vol. 33 Issue 1, p1-1. 8p.

Record details

Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs.

• Authors : Truong, Trang T. T.; Bortolasci, Chiara C.; Kidnapillai, Srisaiyini

Subjects: AMISULPRIDE; ANTIPSYCHOTIC agents; ARIPIPRAZOLE

• Source: International Journal of Molecular Sciences; Jul2022, Vol. 23 Issue 14, p7508-7508, 11p

Record details

Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis.

• Authors : Liu, Zoe S. J.; Truong, Trang T. T.; Bortolasci, Chiara C.

Subjects: PSYCHOPHARMACOLOGY; PROTEIN synthesis; AMISULPRIDE

• Source: International Journal of Molecular Sciences; Jul2022, Vol. 23 Issue 13, p7180-N.PAG, 12p

Record details

A protocol for the first episode psychosis outcome study (FEPOS): ≥15 year follow‐up after treatment at the Early Psychosis Prevention and Intervention Centre, Melbourne, Australia.

• Authors : Cotton, Sue; Filia, Kate; Watson, Amity

Subjects: PSYCHOSES; MEDICAL care; PATIENTS' familiesMELBOURNE (Vic.)

• Source: Early Intervention in Psychiatry; Jul2022, Vol. 16 Issue 7, p715-723, 9p, 2 Diagrams

Record details